Optimal Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

Optimal Asset Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$507K	Hold	15,118	–	–	0.06%	304
2021 Q2	$603K	Hold	15,118	–	–	0.07%	298
2021 Q1	$680K	Sell	15,118 -11,000	-42%	-$613K	0.09%	281
2020 Q4	$1.48M	Sell	26,118 -18	-0.1%	-$897	0.21%	171
2020 Q3	$1.24M	Sell	26,136 -870	-3%	-$48.3K	0.18%	183
2020 Q2	$1.59M	Sell	27,006 -16,569	-38%	-$922K	0.26%	140
2020 Q1	$2.06K	Buy	43,575 +32,117	+280%	+$1.79M	0.19%	183
2019 Q4	$692K	Buy	+11,458	New	+$683K	0.11%	281

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Optimal Asset Management's IONS Position: Q3 2021 in Review

Optimal Asset Management held its Ionis Pharmaceuticals (IONS) position steady in Q3 2021 at 15,118 shares worth $507K. The position accounts for 0.06% of the portfolio, ranked #304.

Optimal Asset Management first reported a position in IONS in Q4 2019 and has held it in 8 quarters since. The position peaked at $1.59M in Q2 2020. 324 funds tracked by Wall St. Rank hold IONS as of Q3 2021.

Optimal Asset Management held 15,118 shares of Ionis Pharmaceuticals worth $507K as of Q3 2021.
Optimal Asset Management left its Ionis Pharmaceuticals share count unchanged in Q3 2021.
Ionis Pharmaceuticals made up 0.06% of Optimal Asset Management's portfolio in Q3 2021, its #304 holding.
Optimal Asset Management first reported a position in Ionis Pharmaceuticals in Q4 2019 and has held it in 8 quarters since.
Optimal Asset Management's Ionis Pharmaceuticals position peaked at $1.59M in Q2 2020.
324 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2021.

Based on Optimal Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.